{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.110.12.1040","meta":{"versionId":"22","lastUpdated":"2022-03-02T18:04:02.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2022-03-02"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1040","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.110.12.1040"}],"version":"20170504","name":"VaricellaZosterVaccineVZVAdministered","title":"Varicella Zoster Vaccine (VZV) Administered","status":"active","experimental":false,"date":"2022-03-03T18:46:01-05:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The purpose of this value set is to represent concepts for a varicella zoster vaccination.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a varicella zoster vaccination.),(Exclusion Criteria: No exclusions.)","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1107"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1106"]}]},"expansion":{"identifier":"urn:uuid:fde4aab0-9802-4f70-a93c-8e0a3f4eaa24","timestamp":"2023-12-11T02:11:05-05:00","total":11,"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"425897001","display":"Administration of first dose of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"428502009","display":"Administration of second dose of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"432636005","display":"Administration of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"433733003","display":"Administration of second dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"572511000119105","display":"Administration of vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus and Human alphaherpesvirus 3 antigens (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"737081007","display":"Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"871898007","display":"Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"871899004","display":"Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen via subcutaneous route (procedure)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"871909005","display":"Administration of first dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90710","display":"Measles, mumps, rubella, and varicella vaccine (MMRV), live, for subcutaneous use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90716","display":"Varicella virus vaccine (VAR), live, for subcutaneous use"}]}}